Patents by Inventor C. Eric Schwartz

C. Eric Schwartz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230115350
    Abstract: The present disclosure provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: July 29, 2022
    Publication date: April 13, 2023
    Inventors: Glen Robert Rennie, C. Eric Schwartz, Louise Kirman, Dale Porter, Ling Song
  • Publication number: 20230098872
    Abstract: The present disclosure provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: March 25, 2022
    Publication date: March 30, 2023
    Inventors: Glen Robert Rennie, C. Eric Schwartz, Louise Kirman, Dale Porter, Ling Song
  • Publication number: 20230053649
    Abstract: The present disclosure provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: June 24, 2022
    Publication date: February 23, 2023
    Inventors: Glen Robert Rennie, C. Eric Schwartz, Dale Porter, Ling Song
  • Publication number: 20160159774
    Abstract: The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
    Type: Application
    Filed: December 3, 2015
    Publication date: June 9, 2016
    Inventors: C. Eric Schwartz, Sekhar S. Surapaneni, Karin Irmgard Worm
  • Patent number: 9315447
    Abstract: The invention relates to novel resolvin compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel resolvin compounds of the invention.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: April 19, 2016
    Assignee: A.T. RESOLVE SARL
    Inventors: Per Gjorstrup, C. Eric Schwartz
  • Publication number: 20140275247
    Abstract: The invention relates to novel resolvin compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel resolvin compounds of the invention.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: A.T. Resolve Sarl
    Inventors: Per Gjorstrup, C. Eric Schwartz
  • Patent number: 8673881
    Abstract: The invention relates to novel resolvin compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel resolvin compounds of the invention.
    Type: Grant
    Filed: April 13, 2010
    Date of Patent: March 18, 2014
    Assignee: A.T. Resolve Sarl
    Inventors: Per Gjorstrup, C. Eric Schwartz
  • Publication number: 20120101061
    Abstract: The invention relates to novel resolvin compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel resolvin compounds of the invention.
    Type: Application
    Filed: April 13, 2010
    Publication date: April 26, 2012
    Inventors: Per Gjorstrup, C. Eric Schwartz
  • Publication number: 20110245528
    Abstract: The invention relates to novel resolvin compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel resolvin compounds of the invention.
    Type: Application
    Filed: September 23, 2009
    Publication date: October 6, 2011
    Inventor: C. Eric Schwartz
  • Publication number: 20100035989
    Abstract: The invention relates to methods of treating mucositis comprising administering a compound of formula A, compound of any one of formulae 1 to 46, lipoxin compound, or oxylipin compound.
    Type: Application
    Filed: July 19, 2007
    Publication date: February 11, 2010
    Inventors: C. Eric Schwartz, Per Gjorstrup
  • Patent number: 5340833
    Abstract: Disclosed are benzothiophene and thienothiophene derivatives useful for inhibiting urokinase activity.
    Type: Grant
    Filed: May 1, 1992
    Date of Patent: August 23, 1994
    Assignee: Eisai Co., Ltd.
    Inventors: Alexander Bridges, Bruce A. Littlefield, C. Eric Schwartz